Journal article
Race, Ethnicity, and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer in the Randomized TAILORx Trial
Abstract
BACKGROUND: Black race is associated with worse outcomes in early breast cancer. We evaluated clinicopathologic characteristics, the 21-gene recurrence score (RS), treatment delivered, and clinical outcomes by race and ethnicity among women who participated in the Trial Assigning Individualized Options for Treatment.
METHODS: The association between clinical outcomes and race (White, Black, Asian, other or unknown) and ethnicity (Hispanic vs …
Authors
Albain KS; Gray RJ; Makower DF; Faghih A; Hayes DF; Geyer CE; Dees EC; Goetz MP; Olson JA; Lively T
Journal
Journal of the National Cancer Institute, Vol. 113, No. 4, pp. 390–399
Publisher
Oxford University Press (OUP)
Publication Date
April 6, 2021
DOI
10.1093/jnci/djaa148
ISSN
0027-8874
Associated Experts
Fields of Research (FoR)
Medical Subject Headings (MeSH)
AdultAgedAsian PeopleBlack PeopleBreast NeoplasmsComorbidityConfidence IntervalsEstrogen Receptor alphaFemaleHispanic or LatinoHumansInsurance CoverageIntracellular Signaling Peptides and ProteinsMenopauseMiddle AgedNeoplasm Recurrence, LocalNuclear ProteinsPrognosisProportional Hazards ModelsProspective StudiesReceptor, ErbB-2Treatment OutcomeWhite PeopleYoung Adult